Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct 28;101(43):e31378.
doi: 10.1097/MD.0000000000031378.

Hereditary motor and sensory neuropathy with SOD1-mutant: A case report

Affiliations
Case Reports

Hereditary motor and sensory neuropathy with SOD1-mutant: A case report

Zhong Luo et al. Medicine (Baltimore). .

Abstract

Rationale: Hereditary motor-sensory peripheral neuropathy, or Charot-Marie-Tooth (CMT) Charcot-Marie-Tooth disease is an inherited peripheral neuropathy characterized by progressive limb weakness and muscle atrophy. As the disease progresses, sensory and autonomic involvement may occur. We report a case of CMT associated with SOD1 gene mutation, in order to provide new ideas for clinical disease diagnosis.

Patient concerns: A 50-years-old female patient was admitted to the hospital with "progressive weakness of the right lower extremity for 5 years, aggravating, and weakness of the left lower extremity for 4 months".

Diagnosis: The patient was diagnosed CMT.

Intervention: Nerve nutrition and rehabilitation therapy were given, but the patient's condition still did not improve significantly.

Outcomes: The improvement of symptoms was not obvious.

Lessons: The clinical manifestations and electromyography results of this patient are consistent with the characteristics of CMT. The peripheral nerve-related hereditary gene test found mutation in SOD1. It is possible that this mutation is linked to CMT. The disease is a neurodegenerative disease, that may be slowed by physical therapy and rehabilitation, but could not be healed.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Gene exon sequencing test report of proband and pedigree.

References

    1. Hoyle JC, Isfort MC, Roggenbuck J, et al. . The genetics of charcot-marie-tooth disease: current trends and future implications for diagnosis and management. Application Clin Genet. 2015;8:235–43. - PMC - PubMed
    1. Timmerman V, Strickland AV, Züchner S. Genetics of charcot-marie-tooth (CMT) Disease within the frame of the human genome project success. Genes. 2014;5:13–32. - PMC - PubMed
    1. Rossor AM, Polke JM, Houlden H, et al. . Clinical implications of genetic advances in charcot-marie-tooth disease. Nat Rev Neurol. 2013;9:562–71. - PubMed
    1. Skre H. Genetic and clinical aspects of charcot-marie-tooth’s disease. Clin Genet. 1974;6:98–118. - PubMed
    1. Stavrou M, Sargiannidou I, Georgiou E, et al. . Emerging therapies for Charcot-Marie-Tooth inherited neuropathies. Int J Mol Sci . 2021;22:6048. - PMC - PubMed

Publication types

MeSH terms